{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:20:13Z","timestamp":1790112013673,"version":"4.0.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cjca.2021.07.224","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T06:06:41Z","timestamp":1628402801000},"page":"S17-S29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Coronary Stenting: Reflections on a 35-Year Journey"],"prefix":"10.1016","volume":"38","author":[{"given":"Bradley H.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Doucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabby","family":"Elbaz-Greener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2021.07.224_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/02841859709172106","article-title":"The origin of the word stent","volume":"38","author":"Hedin","year":"1997","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1084\/jem.16.1.17","article-title":"Permanent intubation of the thoracic aorta","volume":"16","author":"Carrel","year":"1912","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004424-196909000-00008","article-title":"Transluminally-placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery","volume":"4","author":"Dotter","year":"1969","journal-title":"Invest Radiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1148\/radiology.147.1.6828741","article-title":"Transluminal expandable nitinol coil stent grafting: preliminary report","volume":"147","author":"Dotter","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.cjca.2021.07.224_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis","volume":"1","author":"Gruntzig","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib6","first-page":"1311","article-title":"Self-expanding coronary endoprosthesis in the prevention of restenosis following transluminal angioplasty. Preliminary clinical study [in French]","volume":"80","author":"Puel","year":"1987","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.cjca.2021.07.224_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4244\/EIJV4I4A75","article-title":"Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007","volume":"4","author":"Daemen","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2021.07.224_bib10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib11","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Group","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jtcvs.2020.04.010","article-title":"Percutaneous coronary intervention vs coronary artery bypass graft for left main coronary artery disease: a meta-analysis","volume":"163","author":"Gallo","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2021.07.224_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2010.06.007","article-title":"Coronary stents: current status","volume":"56","author":"Garg","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0008-6363(96)00038-7","article-title":"Mechanisms and prevention of restenosis: from experimental models to clinical practice","volume":"31","author":"Bauters","year":"1996","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2021.07.224_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-8703(94)90675-0","article-title":"Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty","volume":"127","author":"de Feyter","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib20","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/S0735-1097(02)01873-9","article-title":"Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor","volume":"39","author":"Li","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199101033240103","article-title":"Angiographic follow-up after placement of a self-expanding coronary-artery stent","volume":"324","author":"Serruys","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0735-1097(93)90093-G","article-title":"Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome","volume":"21","author":"Nath","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib23","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0735-1097(99)00051-0","article-title":"Acute and long-term cost implications of coronary stenting","volume":"33","author":"Peterson","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0735-1097(96)00266-5","article-title":"Results of coronary stenting for restenosis","volume":"28","author":"Colombo","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A\u00a0randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A\u00a0comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. BENESTENT Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A\u00a0randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib28","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0002-8703(98)70168-1","article-title":"Failed coronary stent deployment","volume":"136","author":"Cantor","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.94.6.1247","article-title":"Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study","volume":"94","author":"Hoffmann","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity","volume":"151","author":"Chen","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4244\/EIJV3I2A44","article-title":"\u2018Fused-Gold\u2019 vs \u2018Bare\u2019 stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study","volume":"3","author":"Fort","year":"2007","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2021.07.224_bib32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib33","first-page":"1363","article-title":"Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial","volume":"44","author":"Serruys","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib34","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents vs standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A\u00a0polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","article-title":"Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study","volume":"103","author":"Sousa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib39","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2004.01.024","article-title":"The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)","volume":"43","author":"Schampaert","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib40","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2010.02.009","article-title":"Randomized trial of paclitaxel- vs sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study","volume":"55","author":"Mehilli","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib41","first-page":"359","article-title":"Clinical utility of platinum chromium bare-metal stents in coronary heart disease","volume":"27","author":"Jorge","year":"2015","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.cjca.2021.07.224_bib42","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1017\/S0266462305050439","article-title":"Cost-effectiveness of drug-eluting coronary stents in Quebec, Canada","volume":"21","author":"Brophy","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.cjca.2021.07.224_bib44","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib45","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib46","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMp068305","article-title":"Unanswered questions--drug-eluting stents and the risk of late thrombosis","volume":"356","author":"Maisel","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCINTERVENTIONS.108.844985","article-title":"Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry","volume":"2","author":"Lagerqvist","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2021.07.224_bib48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib49","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs bare metal stents in coronary artery disease: a meta-analysis","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib50","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib51","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib52","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib53","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A\u00a0pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib54","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.39063.481285.DB","article-title":"Drug eluting stents are safe for licensed indications, FDA panel says","volume":"333","author":"Mayor","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2021.07.224_bib55","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa066139","article-title":"Coronary intervention for persistent occlusion after myocardial infarction","volume":"355","author":"Hochman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ahj.2007.07.049","article-title":"Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients","volume":"154","author":"Ioannidis","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention vs coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib58","article-title":"Fall and rise of coronary intervention","volume":"9","author":"Lahoud","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2021.07.224_bib59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/CIRCOUTCOMES.110.957175","article-title":"Recent changes in practice of elective percutaneous coronary intervention for stable angina","volume":"4","author":"Ahmed","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2021.07.224_bib60","article-title":"Temporal trends in percutaneous coronary intervention and coronary artery bypass grafting: insights from the Washington Cardiac Care Outcomes Assessment Program","volume":"9","author":"Kataruka","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2021.07.224_bib61","first-page":"1","article-title":"China cardiovascular diseases report 2015: a summary","volume":"14","author":"Chen","year":"2017","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ihj.2019.04.002","article-title":"The report on the Indian coronary intervention data for the year 2017-National Interventional Council","volume":"71","author":"Arramraju","year":"2019","journal-title":"Indian Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib63","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib64","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib65","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jcin.2016.03.038","article-title":"Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials","volume":"9","author":"Kang","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2021.07.224_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002230","article-title":"Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial","volume":"8","author":"Iqbal","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2021.07.224_bib67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents vs thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib68","first-page":"646","article-title":"Does IVUS guidance of coronary interventions affect outcome? A prime example of the failure of randomized clinical trials","volume":"71","author":"Gerber","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2021.07.224_bib69","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1161\/01.CIR.96.9.2997","article-title":"Comparison of immediate and intermediate-term results of intravascular ultrasound vs angiography-guided Palmaz-Schatz stent implantation in matched lesions","volume":"96","author":"Albiero","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib70","first-page":"120","article-title":"Multicenter clinical experience with the development of a novel short coronary stent and its prototype device","volume":"37","author":"Webb","year":"1996","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1016\/j.cjca.2021.07.224_bib71","first-page":"193","article-title":"Phosphorylcholine-coated stents in porcine coronary arteries: in\u00a0vivo assessment of biocompatibility","volume":"13","author":"Malik","year":"2001","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1540-8183.2004.09881.x","article-title":"Low rates of angiographic and clinical restenosis with the new flexible MedStent for the treatment of single discrete coronary lesions","volume":"17","author":"Segev","year":"2004","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib73","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2005.01.048","article-title":"Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) registry","volume":"45","author":"Aoki","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib74","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10439-015-1458-5","article-title":"Development of a novel biodegradable metallic stent based on microgalvanic effect","volume":"44","author":"Frattolin","year":"2016","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.cjca.2021.07.224_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty vs coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"Holm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib77","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib78","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-year outcomes after PCI or CABG for left main coronary disease","volume":"381","author":"Stone","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib79","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.15420\/ecr.2020.34","article-title":"The EXCEL trial: the surgeons\u2019 perspective","volume":"15","author":"Jahangiri","year":"2020","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib80","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting vs percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data [erratum in: 2018;392:476]","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib81","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jamacardio.2017.2895","article-title":"Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis","volume":"2","author":"Giacoppo","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib82","doi-asserted-by":"crossref","first-page":"174","DOI":"10.15420\/icr.2019.18.R1","article-title":"The Coronary Intravascular Lithotripsy System","volume":"14","author":"Forero","year":"2019","journal-title":"Interv Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib83","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","author":"Giacoppo","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib84","doi-asserted-by":"crossref","first-page":"1042329","DOI":"10.1155\/2020\/1042329","article-title":"Drug-coated balloons vs everolimus-eluting stents in patients with in-stent restenosis: a pair-wise meta-analysis of randomized trials","volume":"2020","author":"Peng","year":"2020","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.cjca.2021.07.224_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17434440.2019.1573142","article-title":"Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone","volume":"16","author":"Chichareon","year":"2019","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.cjca.2021.07.224_bib86","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2016.10.009","article-title":"2-Year outcomes of high bleeding risk patients after polymer-free drug-coated stents","volume":"69","author":"Garot","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib89","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.07.224_bib90","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-Year outcomes from a randomized trial of polymer-free vs durable polymer drug-eluting coronary stents","volume":"76","author":"Kufner","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib91","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.119.040241","article-title":"Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: the SORT OUT IX Trial","volume":"141","author":"Jensen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.07.224_bib92","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jcin.2020.02.019","article-title":"Ultrathin bioresorbable-polymer sirolimus-eluting stents vs thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V Trial","volume":"13","author":"Kandzari","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2021.07.224_bib93","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib94","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents vs durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib95","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.clinthera.2020.02.014","article-title":"Comparison of the ultrathin strut, biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent in a Chinese population: the randomized BIOFLOW VI Trial","volume":"42","author":"Li","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.cjca.2021.07.224_bib96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.acvd.2018.04.001","article-title":"Bioresorbable vascular scaffolds: time to absorb past lessons or fade away?","volume":"111","author":"de Pommereau","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2021.07.224_bib97","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A\u00a0bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib98","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial","volume":"6","author":"Onuma","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2021.07.224_bib99","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.07.224_bib100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_18_19","article-title":"\u201cThe unpredictable ABSORB\u201d - very late stent thrombosis of bioresorbable vascular scaffold","volume":"20","author":"Pradhan","year":"2019","journal-title":"Heart Views"},{"key":"10.1016\/j.cjca.2021.07.224_bib101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ahj.2013.09.017","volume":"167","author":"Woudstra","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib102","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.07.224_bib103","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/eurheartj\/ehw196","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"37","author":"Haude","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.07.224_bib104","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCRESAHA.117.310275","article-title":"Bioresorbable scaffold: the emerging reality and future directions","volume":"120","author":"Sotomi","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2021.07.224_bib105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jbm.b.31918","article-title":"Magnesium used in bioabsorbable stents controls smooth muscle cell proliferation and stimulates endothelial cells in\u00a0vitro","volume":"100","author":"Sternberg","year":"2012","journal-title":"J\u00a0Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.cjca.2021.07.224_bib106","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: Magmaris vs Absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21006231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21006231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:49:27Z","timestamp":1760107767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X21006231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0828282X21006231"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2021.07.224","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary Stenting: Reflections on a 35-Year Journey","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2021.07.224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}